Upadacitinib

Upadacitinib, sold under the brand name Rinvoq, is a medication used for the treatment of rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and axial spondyloarthritis. Upadacitinib is a Janus kinase (JAK) inhibitor that works ...

1 story • Updated Oct 14, 2025
Upadacitinib
Health

FDA Greenlights AbbVie's RINVOQ for Moderate to Severe Ulcerative Colitis

8 sources Oct 13, 2025